Amarin's omega-3 capsule, Vascepa, has the potential to treat millions of patients on traditional statins, says CEO John Thero.
Biopharmaceutical company Amarin is"just getting started" in treating cardiovascular patients, CEO John Thero told CNBC on Wednesday.
"We just doubled the size of our sales force. We will be applying next month to the FDA to get the expanded label," Thero said on"Power Lunch.""Assuming we get approved there, we'll further expand our sales force. There's tens of millions of patients who can potentially benefit from this therapy." The clinical trial showed Vascepa"could help improve heart health even more" for those patients already on traditional statins, Thero said. Statins lower cardiovascular risks by 25 percent to 35 percent, he said.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
The C-Suite Insider: Hilton Hotels CEO says 'I'm not worried' about AirbnbThe C-Suite Insider: Hilton Hotels CEO says 'I'm not worried' about Airbnb.
Consulte Mais informação »
Southwest CEO says mechanics deserve new contract, but company wants 'flexibility'Southwest Airlines Co's mechanics, who have been in labor contract talks fo...
Consulte Mais informação »
As Ex-Enron CEO Exits Prison, Some of Company’s Old Businesses ThriveFormer Enron CEO Jeffrey Skilling re-enters a world in which some of the businesses built from his old company’s less appreciated assets have become formidable in their own right.
Consulte Mais informação »
Zillow CEO Spencer Rascoff Out Amid Pivot To Buying And Selling HomesZillow Group has announced that CEO Spencer Rascoff is out amid the company's pivot to buying and selling homes
Consulte Mais informação »
Elon Musk's promises about self-driving cars are 'almost unethical,' says AutoNation CEOTesla CEO Elon Musk's promises about autonomous vehicle technology are 'almost unethical,' AutoNation CEO Mike Jackson said in an interview with CNBC.
Consulte Mais informação »